Bioanalytical Systems (BASi)
Robert Leasure, Jr. was been elected as the company’s new president, chief executive officer, and director, effective since January 12.
Leasure has worked with the company’s management team since 2016 as well as its board of directors, to develop a growth strategy for the company.
According to the company, BASi’s board believes Leasure's “demonstrated successes, experience, ability to develop and work collaboratively with the management team, and his ability to create and execute upon visions for the future of the company have been, and will continue to be, critical to growing the company’s business and creating long-term shareholder value.”